Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Gilead Sciences Inc (GILD)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 87,741,952
  • Shares Outstanding, K 1,307,240
  • Annual Sales, $ 30,390 M
  • Annual Income, $ 13,501 M
  • 36-Month Beta 1.14
  • Price/Sales 2.85
  • Price/Cash Flow 5.26
  • Price/Book 4.51

Price Performance

See More
Period Period Low Period High Performance
1-Month
65.70 +2.85%
on 04/18/17
68.33 -1.11%
on 03/31/17
+0.06 (+0.09%)
since 03/24/17
3-Month
65.38 +3.35%
on 02/09/17
73.30 -7.82%
on 02/07/17
-3.65 (-5.12%)
since 01/26/17
52-Week
65.38 +3.35%
on 02/09/17
101.78 -33.61%
on 04/27/16
-33.76 (-33.32%)
since 04/26/16

Most Recent Stories

More News
What Awaits Aerie Pharmaceuticals (AERI) in Q1 Earnings?

Aerie Pharmaceuticals, Inc. (AERI) is scheduled to report first-quarter 2017 results on May 2.

AERI : 42.25 (-0.12%)
NVS : 76.05 (-0.25%)
FGEN : 27.80 (-0.71%)
GILD : 67.72 (+0.89%)
Biotech Stock Roundup: Biogen Gains on Strong Q1, NASH Data on Gilead Drug

Focus this week remained on Biogen's (BIIB) first quarter results which surpassed expectations.

CELG : 126.03 (+0.41%)
VRTX : 116.81 (-0.39%)
BMRN : 95.17 (+1.04%)
GILD : 67.72 (+0.89%)
REGN : 373.78 (+0.39%)
AMGN : 165.15 (+0.27%)
BIIB : 284.32 (-0.90%)
Stocks Give an Encore Performance

Stocks Give an Encore Performance

CELG : 126.03 (+0.41%)
DHI : 32.50 (-0.46%)
TEX : 35.64 (-0.06%)
LNCE : 35.07 (-0.65%)
BEAT : 33.10 (+1.69%)
LEA : 141.20 (+0.19%)
CVGI : 9.15 (+2.01%)
WYNN : 123.90 (+4.80%)
WMB : 30.77 (-0.13%)
JUNO : 25.24 (+1.16%)
CTB : 43.75 (+0.92%)
EW : 109.69 (+10.89%)
LMT : 270.51 (+0.18%)
APC : 60.19 (+0.18%)
PCH : 45.05 (-0.44%)
HDSN : 7.27 (-0.27%)
NEM : 32.85 (-0.12%)
LRCX : 145.18 (-0.40%)
INCY : 125.00 (+0.49%)
GILD : 67.72 (+0.89%)
FB : 146.90 (+0.28%)
PTC : 53.60 (-0.17%)
ALXN : 121.50 (+0.79%)
Gilead (GILD) Q1 Earnings: Stock Likely to Beat Estimates?

Gilead Sciences Inc. (GILD) is scheduled to report first-quarter 2017 results on May 2, after the market closes.

ABBV : 65.43 (+0.51%)
GILD : 67.72 (+0.89%)
ICPT : 114.93 (+0.14%)
AMGN : 165.15 (+0.27%)
Exelixis (EXEL) Q1 Earnings: Will the Stock Disappoint?

Exelixis, Inc. (EXEL) is scheduled to report first-quarter 2017 results on May 1, after the market close.

PTI : 5.91 (-0.84%)
EXEL : 21.91 (-0.77%)
GILD : 67.72 (+0.89%)
BMY : 54.53 (+1.09%)
Bristol-Myers (BMY) to Post Q1 Earnings: What's in Store?

Bristol-Myers Squibb Company (BMY) is scheduled to report first-quarter 2017 results on Apr 27, before the opening bell.

MRK : 62.65 (+0.56%)
GILD : 67.72 (+0.89%)
ICPT : 114.93 (+0.14%)
BMY : 54.53 (+1.09%)
Gilead Sciences Rises 1.45% on Heavy Volume: Watch For Potential Pullback

Gilead Sciences (NASDAQ:GILD) traded in a range yesterday that spanned from a low of $66.56 to a high of $67.53. Yesterday, the shares gained 1.4%, which took the trading range above the 3-day high of...

GILD : 67.72 (+0.89%)
SmarTrend Watching for Potential Pullback in Shares of Gilead Sciences After 1.45% Gain

Gilead Sciences (NASDAQ:GILD) traded in a range yesterday that spanned from a low of $66.56 to a high of $67.53. Yesterday, the shares gained 1.4%, which took the trading range above the 3-day high of...

GILD : 67.72 (+0.89%)
Next Resistance Level for Gilead Sciences (GILD) is $66.93

Shares of Gilead Sciences (NASDAQ:GILD) have bullishly opened above the pivot of $66.15 today and have reached the first resistance level of $66.59. Investors may be interested in a cross of the next...

GILD : 67.72 (+0.89%)
eClinical Solutions LLC Appoints New Vice President of Biostatistics

eClinical Solutions LLC, an industry-leading provider of end-to-end data management services and technologies, announced today that Demi Niforos has joined the organization to head their...

ABUS : 3.30 (-1.49%)
GILD : 67.72 (+0.89%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Gilead Sciences, Inc. is an independent biopharmaceutical company that seeks to provide accelerated solutions for patients and the people who care for them. They have a broad-based focus on developing and marketing drugs to treat patients with infectious diseases, including viral infections, fungal infections...

See More

Support & Resistance

2nd Resistance Point 68.04
1st Resistance Point 67.58
Last Price 67.72
1st Support Level 66.61
2nd Support Level 66.10

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.